TEK and glioblastoma: These data indicated that the three-gene signature composed of SOCS3, VEGFA, and TEK, encoding SOCS3, angiogenic cytokine VEGF-A, and the TEK receptor, respectively, can be used independently to predict prognosis of all GBM subclasses.